Rotman Harris bought CNTA
February 1, 2024 · Form 4 insider transaction
Rotman Harris bought 75,000 shares of Centessa Pharmaceuticals plc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
75,000
Price
$0.00
Total value
N/A
InsiderRotman Harris
Role—
SecurityShare Option (right to buy)
Transaction codeA: Grant or award
Transaction dateFebruary 1, 2024
Filing dateFebruary 2, 2024
Shares owned after75,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
1/48th of the shares subject to such option shall vest and become exercisable in equal monthly installments with the first installment vesting on March 1, 2024.; The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.